Executive Summary
This week's digest highlights: In vascular neurosurgery, baseline ASPECTS and reperfusion grade can stratify hemorrhage risk post-thrombectomy, though symptomatic hemorrhage risk remains unchanged, necessitating standard monitoring. For spine surgery, P-15 peptide-enhanced bone graft is a superior alternative to autograft in achieving composite clinical success in single-level TLIF, with attention to...
Owen briefs you on what matters in this week's digest.
Think chief-resident chalk talk: what matters, what changes practice, and where to spend your reading time.
Endovascular / Vascular
Safety and efficacy of low profile flow diverter stents for intracranial aneurysms in small parent vessels: systematic review and meta-analysis.
Research • Endovascular / Vascular • Journal of neurointerventional surgery • 2026-02-16
NR
OLow-profile flow diverters in small parent vessels (≤3.5 mm) are a viable option, particularly for unruptured aneurysms where neurological outcomes are excellent, but their use in ruptured cases carries significantly higher risk.
Study snapshot
Design
Systematic review and meta-analysis
Population
Patients with intracranial aneurysms in small parent vessels (≤3.5 mm)
Intervention
Low-profile flow diverter stents (Silk Vista Baby, FRED Jr, p48 MW)
Comparator
None (single-arm aggregation)
Primary outcome
Favorable neurological outcomes and complete/near-complete aneurysm occlusion
Why it matters
Previously, data on low-profile flow diverters in small parent vessels (≤3.5 mm) were limited to single-center series. This meta-analysis aggregates outcomes from 33 studies, showing favorable neurological outcomes in 94% of cases overall, with acceptable complication rates. Neurointerventionalists could consider these devices as a viable option for small-vessel aneurysms, particularly in unruptured cases where outcomes appear most favorable.
Practice change
Confirms current practice
More context
Key details
- Systematic review and meta-analysis of 33 studies involving 998 patients with 1049 aneurysms.
- Evaluated Silk Vista Baby, FRED Jr, and p48 MW devices for aneurysms in parent vessels ≤3.5 mm.
- Favorable neurological outcomes defined as reported directly or mRS 0-2.
High-yield
NR
Clinical context
This meta-analysis aims to evaluate clinical and angiographic outcomes of low-profile flow diverters used in treating intracranial aneurysms in small parent vessels (≤3.5 mm).
Limitations
Heterogeneity across included studies in reporting standards and follow-up durations.Lack of individual patient data limits adjustment for confounders like aneurysm morphology or antiplatelet regimens.
Methodological critique
Aggregation of heterogeneous studies without individual patient data limits causal inference.
Teaching pearl
When considering a low-profile FD for a small-vessel aneurysm, remember that unruptured status strongly predicts better neurological outcomes—97% vs. 80% in ruptured cases—so timing and patient selection are critical.
Funding and COI
Not stated
Tumor / Skull Base
Maximizing Tumor Resection and Managing Cognitive Attentional Outcomes: Measures of Impact of Awake Surgery in Glioma Treatment.
Research • Tumor / Skull Base • Neurosurgery • 2025-06-20
Awake glioma surgery enables higher non-contrast-enhancing resection but is associated with greater short-term attentional decline; balance resection goals with cognitive monitoring.
OAwake glioma surgery yields greater non-enhancing resection but expect a transient attentional dip requiring specific monitoring and patient counseling.
Study snapshot
Design
Cohort study
Population
64 consecutive glioma patients (no prior brain surgery, with pre/post MRI and neuropsych assessment)
Intervention
Awake surgery with cortical/subcortical mapping
Comparator
Asleep surgery
Primary outcome
Attentional decline (delta scores on matrices and TMT-A) and non-contrast-enhancing extent of resection
Why it matters
Awake surgery for glioma is known to maximize resection, but its impact on attentional functions was poorly characterized. This study shows that awake surgery leads to greater transient attentional decline postoperatively compared to asleep surgery, despite achieving higher non-contrast-enhancing resection. Surgeons should be aware that awake mapping, while enabling more extensive resection, may come at a short-term cognitive cost that requires monitoring and patient counseling.
Practice change
Confirms current practice
More context
Key details
- Cohort of 64 consecutive glioma patients (42 men, mean age 53.3) undergoing awake (54.7%) or asleep (45.3%) surgery.
- All patients achieved gross-total resection; non-contrast-enhancing extent of resection (EOR) was higher in awake group (68.9% vs. 42.7%, p<.01).
High-yield
NR
Clinical context
This study investigates the impact of awake surgery on attentional outcomes in glioma treatment, given that attentional functions are often monitored indirectly during awake procedures.
Limitations
Non-randomized design with baseline differences between groups (e.g., tumor grade, preoperative scores).Small sample size and single-center nature limit generalizability.
Methodological critique
Non-randomized cohort with significant baseline imbalances limits causal attribution of outcomes to surgical approach.
Teaching pearl
When planning awake glioma surgery, anticipate a transient attentional dip postoperatively—monitor with matrices and TMT-A, and counsel patients that this may be the trade-off for maximizing non-enhancing resection.
Funding and COI
Not stated
Spine
Does Advanced Age Negatively Impact Treatment Outcomes of Cervical Ossification of the Posterior Longitudinal Ligament? A Prospective Multicenter Study.
Research • Spine • Spine • 2025-06-03
Elderly cervical OPLL patients achieve comparable neurological improvement to younger patients after surgery, but upper extremity function recovery may be limited.
OElderly OPLL patients achieve similar overall JOA recovery after surgery, but counsel that fine hand function may not fully rebound.
Study snapshot
Design
Multicenter prospective cohort study
Population
402 cervical OPLL patients, categorized into elderly (≥75 yr) and nonelderly (<75 yr)
Intervention
Surgical treatment for cervical OPLL
Comparator
Nonelderly patients (<75 yr)
Primary outcome
JOA score improvement and JOACMEQ outcomes at 2 years postoperatively
Why it matters
Elderly patients with cervical OPLL often present with worse baseline myelopathy, but it was unclear whether they benefit similarly from surgery. This prospective study shows that elderly (≥75 years) achieve comparable neurological improvement to younger patients, though upper extremity function may not improve as much. Spine surgeons can reassure elderly OPLL patients that surgery is likely to provide meaningful neurological recovery, but set realistic expectations about hand function.
Practice change
Confirms current practice
More context
Key details
- Multicenter prospective cohort of 402 cervical OPLL patients, categorized into elderly (≥75 yr, n=79) and nonelderly (<75 yr, n=323).
- Assessed with JOA scores, VAS, and JOACMEQ preoperatively and at 2 years postoperatively.
- Elderly had worse preoperative JOA (9.6 vs. 11.1, p<0.01) and postoperative scores (12.3 vs. 14.0, p<0.01), but improvement was comparable (2.7 vs. 3.0, p=0.48).
- Both groups exceeded minimum clinically important difference in JOA improvement.
- Complication rates and VAS improvements were comparable between groups.
- JOACMEQ showed significantly poorer upper extremity function in elderly postoperatively (p=0.02), with no differences in other domains.
- Multivariable regression adjusted for demographics and imaging characteristics.
High-yield
NR
Clinical context
With aging populations, understanding the impact of age on treatment outcomes for cervical OPLL has become increasingly important, with limited prior focus on patient-reported outcomes.
Limitations
Non-randomized design with potential unmeasured confounders affecting group comparisons.Lack of long-term follow-up beyond 2 years limits assessment of durability.
Methodological critique
Prospective cohort design without randomization may introduce selection bias despite multivariable adjustment.
Teaching pearl
For elderly OPLL patients, focus on the JOA improvement—it’s similar to younger patients—but temper expectations about fine motor hand function, which may not recover as well.
Funding and COI
Not stated
Functional
Long-term memory trajectories in seizure-free patients following epilepsy surgery for hippocampal sclerosis.
Research • Functional • Epilepsia • 2025-10-03
For TLE/HS surgery candidates, emphasize that left-sided resections carry substantially higher risk of verbal memory decline, particularly in patients with normal preoperative memory scores.
OLeft-sided TLE/HS resections, especially in patients with normal preoperative verbal memory, carry a high risk of long-term decline (RR ~4), so quantify this risk explicitly during consent.
Study snapshot
Design
Single-center cross-sectional study with long-term follow-up
Population
Seizure-free patients with hippocampal sclerosis who underwent anterior temporal lobectomy or selective amygdalohippocampectomy
Intervention
Epilepsy surgery for TLE/HS
Comparator
None (single-arm longitudinal assessment)
Primary outcome
Memory performance changes using reliable change index on standardized neuropsychological tests
Why it matters
We knew that epilepsy surgery for hippocampal sclerosis carries a risk of memory decline, particularly in patients with better-preserved preoperative function, but most data came from short-term follow-up. This study adds that in seizure-free patients followed for over a decade, memory trajectories stabilize long-term, with left-sided resections showing greater vulnerability to decline in verbal memory. Clinicians should consider that while early postoperative memory changes may occur, long-term stabilization is likely in seizure-free patients, but counsel left-sided surgery patients more carefully about verbal memory risks.
Practice change
Confirms current practice of careful preoperative counseling about memory risks, particularly for left-sided resections.
More context
Key details
- 54 seizure-free TLE/HS patients followed for mean 15.5 years
- 34 patients (63%) had left-sided resections
- Left-sided patients had significantly worse logical memory outcomes at both early (p=.002) and late (p=.013) follow-up
- RAVLT outcomes also significantly worse for left-sided patients at both timepoints (p=.002 at T2, p=.008 at T3)
- Patients with normal preoperative scores had higher risk of postoperative decline
- Used reliable change index with 90% CI to minimize practice effects
- 56% of patients had discontinued antiseizure medications by late follow-up (p<.001)
High-yield
In seizure-free TLE/HS patients followed for a mean 15.5 years, left-sided resections had significantly worse verbal memory outcomes than right-sided, with risk ratios up to 3.95 for worsening in those with normal preoperative scores.
Clinical context
Epilepsy surgery for TLE/HS carries risk of memory decline, particularly with better-preserved preoperative function. Most postoperative memory assessments occur within first few years, with limited long-term data.
Limitations
Single-center, cross-sectional design with potential selection bias (only seizure-free patients included)Small sample size (n=54) limits generalizability and statistical power for subgroup analyses
Methodological critique
The study's cross-sectional design and inclusion of only seizure-free patients may limit generalizability to the broader TLE/HS surgical population.
Teaching pearl
When counseling TLE/HS patients about memory risks, remember that left-sided resections carry significantly higher risk for verbal memory decline, especially in those with normal preoperative scores—use the 3.95 RR for RAVLT worsening to quantify this risk during informed consent discussions.
Funding and COI
Not stated
General Neurosurgery
External Ventricular Drain Versus Intraparenchymal Pressure Monitor in Severe Traumatic Brain Injury: A TRACK-TBI Study.
Research • General Neurosurgery • Neurosurgery • 2025-06-30
NR
ODevice choice for ICP monitoring in severe TBI should hinge on safety and technical factors, not expected outcome differences, as 6-month functional results are comparable.
Study snapshot
Design
Multicenter observational cohort study
Population
Adults ≥17 years with severe nonpenetrating TBI (GCS 3-8)
Intervention
ICP monitoring with external ventricular drain
Comparator
ICP monitoring with intraparenchymal monitor
Primary outcome
6-month Glasgow Outcome Scale-Extended for TBI
Why it matters
We knew that both EVDs and IPMs are used for ICP monitoring in severe TBI, but debate persisted about whether device choice affects outcomes. This multicenter study adds that there were no significant differences in 6-month functional outcomes between the two devices after propensity weighting. Clinicians should base device selection on technical factors and institutional preference rather than expecting outcome differences.
Practice change
Confirms current practice that device selection should be based on clinical factors rather than expected outcome differences.
More context
Key details
- Multicenter cohort study from 18 TRACK-TBI centers
- 189 severe TBI patients (GCS 3-8)
- 115 patients with EVD, 74 with IPM
High-yield
NR
Clinical context
EVDs and IPMs are the two most common ICP-monitoring devices in TBI. Debate remains about whether device selection affects patient outcomes.
Limitations
Observational design with potential residual confounding despite propensity weightingDevice selection was not randomized, reflecting real-world practice patterns
Methodological critique
The observational design with non-randomized device assignment limits causal inference despite propensity weighting adjustments.
Teaching pearl
When choosing between EVD and IPM for severe TBI, focus on which device you can place most safely and manage most effectively—this study suggests functional outcomes at 6 months won't differ based on your choice alone.
Funding and COI
Not stated
Basic Science
Transplantation of engineered spinal cord organoids restores functions after spinal cord injury.
Research • Basic Science • Brain : a journal of neurology • 2025-12-19
Engineered spinal cord organoids show preclinical promise for SCI repair but remain far from clinical application.
OEngineered spinal cord organoids show preclinical promise for functional integration after SCI, but clinical translation remains distant due to the immense complexity of human spinal cord repair.
Study snapshot
Design
Preclinical basic science study
Population
Mouse model of complete spinal cord injury
Intervention
Transplantation of engineered human spinal cord organoids
Comparator
None (single-arm preclinical study)
Primary outcome
Functional recovery of sensory and motor functions
Why it matters
We knew that spinal cord injury repair remains challenging due to limited neural regeneration and integration. This preclinical study adds that engineered spinal cord organoids using a novel nanomaterial scaffold can survive long-term, integrate with host tissue, and restore sensory and motor function in complete SCI mice. Clinicians should recognize this as promising but preliminary evidence that organoid transplantation could eventually become a therapeutic strategy.
Practice change
Does not change current practice but may support future research directions in spinal cord injury repair.
More context
Key details
- Preclinical study using engineered human spinal cord organoids (ChSOs)
- Novel blood vessel-mimicking nanomaterial scaffold combining carboxylated cellulose nanofibers with Matrigel
- Organoids demonstrated self-elongating axon tracts and robust myelination
- Transplanted organoids generated multiple spinal cord neuron subtypes
- Organoids migrated and integrated with host spinal cord tissue
- NTN1 secretion enhanced axonogenesis
- Restored sensory and motor functions in complete SCI mouse model
- Platform for studying neural development and spinal cord repair
High-yield
NR
Clinical context
Generating functional neural organoids to replace damaged central nervous tissue remains challenging. Spinal cord injury repair requires neural regeneration and integration.
Limitations
Preclinical mouse model with uncertain translatability to human spinal cord injuryLong-term safety and immune response data not provided
Methodological critique
As a preclinical study, direct clinical applicability is limited without human trials.
Teaching pearl
When discussing SCI repair strategies with residents, highlight that engineered organoids represent a promising next-generation approach—they're not just cell clusters but self-organizing neural networks that can integrate and secrete trophic factors like NTN1 to enhance host repair.
Funding and COI
Not stated